Page 24 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine Diagnostics gude of biliary tract cancer

system: Review of techniques and applications. Clin Imaging. doi: 10.3390/diagnostics11020252
2021;71:160-169.
111. Mayerhoefer ME, Materka A, Langs G, et al. Introduction to
doi: 10.1016/j.clinimag.2020.10.056 radiomics. J Nucl Med. 2020;61(4):488-495.
102. Vaquero JJ, Kinahan P. Positron emission tomography: doi: 10.2967/jnumed.118.222893
Current challenges and opportunities for technological 112. Liu QP, Tang J, Chen YZ, et al. Immuno-genomic-radiomics
advances in clinical and preclinical imaging systems. Annu to predict response of biliary tract cancer to camrelizumab
Rev Biomed Eng. 2015;17:385-414.
plus GEMOX in a single-arm phase II trial. JHEP
doi: 10.1146/annurev-bioeng-071114-040723 Rep. 2023;5(7):100763.
103. Arslan E, Çermik TF. PET/CT variants and pitfalls in liver, doi: 10.1016/j.jhepr.2023.100763
biliary tract, gallbladder and pancreas. Semin Nucl Med. 113. Koçak B, Durmaz EŞ, Ateş E, Kılıçkesmez Ö. Radiomics
2021;51(5):502-518.
with artificial intelligence: A practical guide for beginners.
doi: 10.1053/j.semnuclmed.2021.04.006 Diagn Interv Radiol. 2019;25(6):485-495.
104. Lan L, Zhang S, Xu T, et al. Prospective comparison of doi: 10.5152/dir.2019.19321
68Ga-FAPI versus 18F-FDG PET/CT for tumor staging in 114. Bo Z, Chen B, Yang Y, et al. Machine learning radiomics to
biliary tract cancers. Radiology. 2022;304(3):648-657.
predict the early recurrence of intrahepatic cholangiocarcinoma
doi: 10.1148/radiol.213118 after curative resection: A multicentre cohort study. Eur J Nucl
Med Mol Imaging. 2023;50(8):2501-2513.
105. Lamarca A, Barriuso J, Chander A, et al.
18F-fluorodeoxyglucose positron emission tomography doi: 10.1007/s00259-023-06184-6
(18FDG-PET) for patients with biliary tract cancer: Systematic 115. Gupta P, Kambadakone A, Sirohi B. Editorial: Role of
review and meta-analysis. J Hepatol. 2019;71(1):115-129.
imaging in biliary tract cancer: Diagnosis, staging, response
doi: 10.1016/j.jhep.2019.01.038 prediction and image-guided therapeutics. Front Oncol.
2024;14:1387531.
106. Goel S, Aggarwal A, Iqbal A, Gupta M, Rao A, Singh S.
18-FDG PET-CT should be included in preoperative staging doi: 10.3389/fonc.2024.1387531
of gall bladder cancer. Eur J Surg Oncol. 2020;46(9):1711-1716.
116. Fernandez Y, Viesca M, Arvanitakis M. Early diagnosis
doi: 10.1016/j.ejso.2020.04.015 and management of malignant distal biliary obstruction:
A review on current recommendations and guidelines. Clin
107. Karagyozov P, Boeva I, Tishkov I. Role of digital single-operator
cholangioscopy in the diagnosis and treatment of biliary Exp Gastroenterol. 2019;12:415-432.
disorders. World J Gastrointest Endosc. 2019;11(1):31-40. doi: 10.2147/CEG.S195714
doi: 10.4253/wjge.v11.i1.31 117. Cha JM, Kim MH, Jang SJ. Early bile duct cancer. World J
Gastroenterol. 2007;13(25):3409-3416.
108. Feng Y, Liang Y, Liu Y, et al. Digital cholangioscopy-assisted,
direct visualization-guided, radiation-free, endoscopic doi: 10.3748/wjg.v13.i25.3409
retrograde intervention for cholelithiasis: Technical feasibility, 118. Bao F, Liu J, Chen H, Miao L, Xu Z, Zhang G. Diagnosis
efficacy, and safety. Surg Endosc. 2024;38(3):1637-1646.
biomarkers of cholangiocarcinoma in human bile: An
doi: 10.1007/s00464-024-10684-3 evidence-based study. Cancers (Basel). 2022;14(16):3921.
109. Wakai T, Nagahashi M, Shimada Y, Prasoon P, Sakata J. doi: 10.3390/cancers14163921
Genetic analysis in the clinical management of biliary tract 119. Colli A, Fraquelli M, Casazza G, et al. Accuracy of
cancer. Ann Gastroenterol Surg. 2020;4(4):316-323.
ultrasonography, spiral CT, magnetic resonance, and
doi: 10.1002/ags3.12334 alpha-fetoprotein in diagnosing hepatocellular carcinoma:
A systematic review. Am J Gastroenterol. 2006;101(3):513-23.
110. Kato S. Tumour-agnostic therapy for pancreatic cancer and
biliary tract cancer. Diagnostics (Basel). 2021;11(2):252. doi: 10.1111/j.1572-0241.2006.00467.x

Volume 3 Issue 1 (2025) 16 doi: 10.36922/arnm.4557